Systemic sclerosis and occupational exposure: Towards an extension of legal recognition as occupational disorder in 2014?;Sclérodermie systémique et exposition professionnelle: Vers une extension de la reconnaissance de maladie professionnelle en 2014?

Revue de Medecine Interne

Volumn 35, Issue 10, 2014, Pages 631-635

  Marie, I ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Crystalline silica; Ketones; Occupational factors; Solvents; Systemic sclerosis; Trichloroethylene; Welding fumes

Indexed keywords

ARTICLE; LEGAL ASPECT; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; SYSTEMIC SCLEROSIS; ADVERSE EFFECTS; CLASSIFICATION; COMPLICATION; HUMAN; LAW; LEGISLATION AND JURISPRUDENCE; LUNG BURN; OCCUPATIONAL DISEASES; SCLERODERMA, SYSTEMIC; WELDING;

EPOXIDE; SILICON DIOXIDE; SOLVENT; VINYL CHLORIDE; VOLATILE ORGANIC COMPOUND;

EPOXY COMPOUNDS; HUMANS; LEGISLATION AS TOPIC; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; SCLERODERMA, SYSTEMIC; SILICON DIOXIDE; SMOKE INHALATION INJURY; SOLVENTS; VINYL CHLORIDE; VOLATILE ORGANIC COMPOUNDS; WELDING;

EID: 84921609064     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2014.04.002     Document Type: Article

References (24)

1. Silman A.J., Howard Y., Hicklin A.J., Black C. Geographical clustering of scleroderma in south and west London. Br J Rheumatol 1990, 29:93-96.
2. Marie I. Étiopathogénie des sclérodermies. Rev Prat 2002, 52:1873-1881.
3. Maître A., Hours M., Bonneterre V., Arnaud J., Tülin Arslan M., Carpentier P., et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 2004, 31:2395-2401.
4. Bramwell B. Diffuse scleroderma: its frequency and occurrence in stonemasons; its treatment by fibrinolysin: elevations of temperature due to fibrinolysin injections. Edinb Med J 1914, 12:387.
5. Erasmus L.D. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 1957, 3:209-231.
6. Calvert G.M., Rice F.L., Boiano J.M., Sheehy J.W., Sanderson W.T. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003, 60:122-129.
7. Englert H., O'connor H., Small-McMahon J., Chambers P., Davis K., Brooks P. Male systemic sclerosis and occupational silica exposure - a population based study. Aust N Z J Med 2000, 30:215-220.
8. Silman A.J., Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?. Ann Rheum Dis 1992, 51:1322-1324.
9. Sluis-Cremer G.K., Hassel P.A., Nizdo E.H., Churchill A.R., Zeiss E.A. Silica, silicosis and progressive systemic sclerosis. Br J Ind Med 1985, 41:838-843.
10. Haustein U.F., Ziegler V., Hermann K., Mehlhorn J., Schmidt C. Silica-induced scleroderma. J Am Acad Dermatol 1990, 22:444-448.
11. Miller F.W., Alfredsson L., Costenbader K.H., Kamen D.L., Nelson L.M., Norris J.M., et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 2012, 39:259-271.
12. Diot E., Lesire V., Guilmot J.L., Metzger M.D., Pilore R., Rogier S., et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002, 59:545-549.
13. Marie I., Gehanno J.F., Bubenheim M., Duval-Modeste A.B., Joly P., Dominique S., et al. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 2014, 13:151-156.
14. Costenbader K.H., Gay S., Alarcón-Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun Rev 2012, 11:604-609.
15. Gómez-Puerta J.A., Gedmintas L., Costenbader K.H. The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis. Autoimmun Rev 2013, 12:1129-1135.
16. Reinl W. Sklerodermie durch trichloräthylen-einwirkung?. Zent F Arbeitsmd u Arbettsschutz 1957, 7:58-60.
17. Bovenzi M., Barbone F., Pisa F.E., Betta A., Romeo L., Tonello A., et al. À case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 2004, 77:10-16.
18. Garabrant D.H., Lacey J.V., Laing T.J., Gillepsie B.W., Mayes M.D., Cooper B.C. Scleroderma and solvent exposure among women. Am J Epidemiol 2003, 157:493-500.
19. Kettaneh A., Al M.O., Tiev K.P., Chayet C., Toledano C., Fabre B., et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol 2007, 34:97-103.
20. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Knapp R.G., Hoel D.G., et al. Is occupational organic solvent exposure a risk factor for scleroderma?. Arthritis Rheum 1998, 41:1111-1118.
21. Cooper G.S., Makris S.L., Nietert P.J., Jinot J. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Perspect 2009, 117:696-702.
22. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 2000, 112-113:421-432.
23. Ishikawa O., Warita S., Tamura A., Miyachi Y. Occupational scleroderma. A 17-year follow-up study. Br J Dermatol 1995, 133:786-789.
24. Hallé O., Schaeverbeke T., Bannwarth B., Dehais J. Les facteurs d'environnement et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. Rev Med Interne 1997, 18:219-229.